P P PP
PRESCRIBERS 1ST EDITION BY LUO K
P P P P P
AYINGO TEST BANK | 2024 UPDATE
P P P P P
, Table of Contents
P P
ChapterP 1:PAnPIntroductionPtoPEvidence-BasedPClinicalP PracticePGuidelines .............................................. 3
ChapterP2:PPharmacokineticsP /Chapter3:PPharmacodynamics ..................................................................... 13
Chapter4:PPharmacogeneticsP andPPharmacogenomics ................................................................................ 25
ChapterP 5:PPharmacologyPAcrossPthePLifePSpan ......................................................................................... 30
ChapterP 6:PDrug-TherapyPPrescribingPinPSpecialPPopulations .................................................................... 36
ChapterP 7:PDrugPDevelopmentP andPApproval ............................................................................................. 45
ChapterP8-ChapterP10:PFoundationsPofPPrescriptionPWritingPChapterP9:PResponsibleControlled-
SubstancePPrescribingPChapterP10:PAntibioticPStewardship......................................................................... 51
ChapterP 11:PAppliedPCalculationsPforP Prescribing ...................................................................................... 58
ChapterP12-:PPromotingPAdherencePWithPPharmacotherapyPII:PSystem-SpecificPandPPatient-
FocusedPPrescribingPChapterP13:PPharmacotherapyPforPEar,PNose,PMouth,PandThroatPConditionsP/ChapterP
14:PPharmacotherapyPforPEyePConditions .................................................................................................... 67
ChapterP15:PPharmacotherapyPforP SkinPConditions .................................................................................... 74
ChapterP 16:PPharmacotherapyPforP NeurologicP Conditions .......................................................................... 81
ChapterP 17:PPharmacotherapyPforP CardiovascularP Conditions ................................................................... 94
ChapterP 18:PPharmacotherapyPforP RespiratoryPConditions ....................................................................... 106
ChapterP19:PPharmacotherapyPforPGastrointestinalPConditionsPandPConditionsPRequiringNutritionalPSuppo
rt ................................................................................................................................................................ 117
ChapterP 20:PPharmacotherapyPforP GenitourinaryPConditions ................................................................... 128
ChapterP21:PPharmacotherapyPforP Renal,PAcid–Base,P Fluid,PandPElectrolytePDisorders .......................... 133
ChapterP 22:PPharmacotherapyPforP MusculoskeletalPandPRheumatologicPConditions ............................... 146
ChapterP23:PTherapeuticP ApplicationsP ofPImmunologyPandPVaccines...................................................... 158
ChapterP 24:PPharmacotherapyPforP EndocrinePDisorders ........................................................................... 163
ChapterP25:PPharmacotherapyPforPHematologicPDisorders ....................................................................... 174
ChapterP 26:PHematology/OncologyPandPSupportivePCarePforPthePNononcologist..................................... 190
ChapterP 27:PPharmacotherapyP RelatedPtoPWomen’sPHealthPConditions................................................... 196
ChapterP28:PPharmacotherapyPRelatedPtoPMen’sP HealthPConditions ........................................................ 211
ChapterP 29:PPharmacotherapyPRelatedPtoPTransgenderP Care .................................................................... 217
ChapterP 30:PAntimicrobialPPharmacotherapy ............................................................................................ 224
ChapterP 31:PAntiretroviralPPharmacotherapy ............................................................................................ 235
ChapterP32:PPsychopharmacologyPandPIntegrativePHealth:PCombinedPTreatmentPofPsychiatricPandPNeuroc
ognitiveP Conditions.................................................................................................................................... 247
ChapterP 33:PPharmacotherapyPforPPainPManagement ............................................................................... 257
ChapterP34:PSubstancePUsePDisorderP III:PHealthPPromotionPandPMaintenance......................................... 267
ChapterP35:POver-the-CounterP Medications .............................................................................................. 283
ChapterP36:PPharmacotherapyPforPObesity ................................................................................................ 291
,ChapterP1:PAnPIntroductionPtoPEvidence-BasedPClinicalPPracticePGuidelines
MULTIPLEPCHOICE
• WhatPisPthePprimaryPpurposeP ofPthePnursingP assessment?
A. IdentifyingP underlyingP pathologicP conditions
B. AssistingP thePphysicianPinPidentifyingPmedicalP conditions
C. DeterminingP thePpatientsPmentalPstatus
D. ExploringP patientP responsesPtoP healthP problems
ANS:PD
APnursingPassessmentPisPdonePtoPidentifyPthePpatientsPresponsePtoPhealthPpro
blems.PDuringPthePnursingPassessmentPphase,PaPcomprehensivePinformationP
basePisPdevelopedPthroughPaPphysicalPexamination,PnursingPhistory,Pmedicat
ionPhistory,PandPprofessionalPobservation.PIdentifyingPunderlyingPpathologi
cPconditionsPandPassistingPthePphysicianPinPidentifyingPmedicalPconditionsPi
sPnotPpartPofPthePnursingPprocess.PDeterminingPthePpatientsP mentalPstatusP isP
onePpartP ofPtheP nursingP assessment,P butP itP isP notPthePprimaryPpurpose.
DIF:PCognitivePLevel:PComprehensionP
REF:PdmP36POBJ:P1P|P3PTOP:PNursingP
ProcessPStep:PAssessment
MSC:PNCLEXP ClientPNeedsP Category:P HealthPPromotionPandP Maintenance
• WhatPisPthePbasisPofPthePNANDAPIP taxonomy?
A. FunctionalPhealthPpatterns
B. HumanPresponsePpatterns
C. BasicP humanP needs
D. PathophysiologicP needs
ANS:PB
TheP NANDAP IP taxonomyP identifiesP humanP responseP patterns.PFunction
alPcomponentsPofPhealthPpatternsParePlimitedPtoPactivity,PfluidPvolume,Pnutr
ition,PselfPcare,PandPsensoryPperception.PBasicPhumanPneedsPcomprisePlessP
thanPmerelyPhealthPpatterns.P PathophysiologicPneedsP arePnotPpartPofPthePsc
opePofPNANDAPI.
, DIF:PCognitivePLevel:PKnowledgePRE
F:Ppp.P37-38POBJ:P5PTOP:
NursingPProcessPStep:PDiagnosis
MSC:PNCLEXP ClientP NeedsP Category:PPhysiologicalP Integrity
• WhichPtaskPisPincludedP inPthePassessmentPstepP ofPthePnursingP process?
A. EstablishingP patientP goals/outcomes
B. ImplementingP theP nursingPcarePplanP (NCP)
C. MeasuringP goal/outcomeP achievement
D. CollectingPandP communicatingP data
ANS:PD
DataParePcollectedPandPcommunicatedPinPthePassessmentPphasePofPthePnursin
gPprocess.PEstablishingPgoalsPisPthePfunctionPofPplanning.
ImplementingPthePNCPPisPthePfunctionPofPimplementation.PMeasuringPoutco
mePachievementPisPthePfunctionPofPevaluation.
DIF:PCognitivePLevel:PComprehensionP
REF:PdmP36POBJ:P2P|P3PTOP:PNursingP
ProcessPStep:PAssessment
MSC:PNCLEXP ClientPNeedsP Category:P HealthPPromotionPandP Maintenance
• WhichPstatementPregardingP nursingPdiagnosesP isP accurate?
a. NursingPdiagnosesPremainPthePsameP forPasP longPasPthePdiseaseP isP present.
b. NursingP diagnosesP arePwrittenPtoPidentifyPdiseasePstates.
c. NursingPdiagnosesPdescribeP patientPproblemsPthatP nursesP treat.
d. NursingPdiagnosesP identifyPcausesP relatedPtoPillness.
ANS:PC
DiagnosticPstatementsPidentifyPproblemsPaPnursePisPindependentlyPablePtoPtr
eatPwithinPthePscopePofPprofessionalPpractice.PNursingPdiagnosesPvaryPwithP
thePchangingPconditionPofPthePpatient.PThePresponsePpatternsParePuniquePtoPt
hePpatientPandParePnotPdiseasePspecific.PNursingPdiagnosesPdescribePthePpati
entsPhumanPresponsePpattern.
DIF:P CognitiveP Level:P Comprehension